Expertise in

conditions

Yoshihide Asano

Sendai, JP

Expertise in

conditions

Sendai, JP

Overview

Yoshihide Asano practices practicing medicine in Sendai, Japan.

Asano is highly rated in 23 conditions, according to our data. Their clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Cutaneous T-Cell Lymphoma (CTCL), and Localized Scleroderma.

They are actively involved in clinical research, co-authoring 428 peer reviewed articles and participating in 2 clinical trials.

Locations

Sendai, Japan

Other Locations

Japan

Tohoku, Japan

Tokyo, Japan

Bunkyo, Japan

Kanazawa, 9208640, Japan

Tsuruga, 9148502, Japan

Hongo, 1138655, Japan

Okayama, Japan

Osaka, 5458585, Japan

Asahi, 5458585, Japan

Toyoake, Japan

Kan'onjicho, 7691695, Japan

Suita, Japan

Sayo, 6795143, Japan

Niigata, Japan

Sagamihara, Japan

Tsukuba, 3050006, Japan

Higashigotanda, 1418625, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3

Enrollment Status: Terminated

Publish Date: March 21, 2023

Intervention Type: Drug

Study Drug: Mirikizumab

Study Phase: Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2

Enrollment Status: Completed

Publish Date: March 30, 2021

Intervention Type: Drug

Study Phase: Phase 3

View 1 Less Clinical Trial

428 Total Publications

Improvement of interstitial lung disease during brodalumab treatment in a patient with psoriasis and systemic immune-mediated inflammation.

Journal: European journal of dermatology : EJD

Published: September 06, 2026

View All 428 Publications

Frequently Asked Questions about Yoshihide Asano

Is Yoshihide Asano a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Yoshihide Asano is classified as an Elite expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yoshihide Asano participate in research or clinical trials?

Yes. Yoshihide Asano has published 428 articles and abstracts on conditions like Scleroderma. You can view a list of Yoshihide Asano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Asano's expertise for a condition

ConditionClose